A Phase 1 Study of KHK4083 in Healthy Volunteers and Subjects With Ulcerative Colitis

PHASE1CompletedINTERVENTIONAL

Enrollment

155

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

December 26, 2017

Study Completion Date

December 26, 2017

Conditions

Healthy Men and Subjects With Ulcerative Colitis

Interventions

DRUG

KHK4083

DRUG

Placebo

Trial Locations (1)

Tokyo

All Listed Sponsors

lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT02985593 - A Phase 1 Study of KHK4083 in Healthy Volunteers and Subjects With Ulcerative Colitis | Biotech Hunter | Biotech Hunter